Federal contractor · WILMINGTON, DE
ASTRAZENECA PHARMACEUTICALS LP
ASTRAZENECA PHARMACEUTICALS LP received $500 in federal contract obligations in FY2026, on 1 awards. Since FY2017: $1.2B. Its largest customer was Defense Logistics Agency ($500).
- Obligations · FY2026
- $500
- New awards
- 1
- Sole-source
- 0.0%
- Single offer
- 0.0%
- UEI
- E5K2ZJ8CTJH4
- Parent company
- ASTRAZENECA UK LTD
Company family
Grouped from reported parent companies (UEI) and, where marked, AI judgments that two records name the same organization or group.
3 registered entities of the same company or corporate group, $734.1K in FY2026 together.
- ASTRAZENECA PHARMACEUTICALS LPWILMINGTON, DE · Family page$500
- ALEXION PHARMACEUTICALS INCNEW HAVEN, CT$733.6K
- MEDIMMUNE LLCGAITHERSBURG, MD$0
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 500FY2017
- 500FY2018
- 6.5KFY2019
- 443.2MFY2020
- 214.6MFY2021
- 575.9MFY2022
- -13KFY2023
- 500FY2024
- -19.8KFY2025
- 500FY2026
Top buying agencies
Obligations in FY2026.
- Defense Logistics Agency$500100%1 awards
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
- Health & medical$500100%
Where the work was performed
- New Castle County, DE$500100%
Integrity signals
Shares of the year's obligations, next to the country's.
- Low competition0.0%US 39% · $0
- Sole-source awards0.0%US 30% · $0
- Single-offer competitions0.0%US 8.7% · $0
- Urgency justifications0.0%US 5.1% · $0
A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.
Exclusions in SAM.gov
Records of the SAM.gov exclusions list (parties debarred, suspended, proposed for debarment or otherwise excluded) matched to this recipient by its Unique Entity ID or CAGE code.
This section could not be loaded right now. Reload the page to try again.
Largest awards
- Defense Logistics Agency· New Castle County, DE· Health & medical· Nov 3, 2025 – Nov 3, 2025· SPE2D026F0023
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
ASTRAZENECA PHARMACEUTICALS LP received $0 in federal assistance in FY2026, on 0 actions (0 new awards).
- Assistance · FY2026
- $0
- New awards
- 0
- Actions
- 0
- Since FY2021
- $8.3M
Assistance by fiscal year
- 3MFY2021
- 2.2MFY2022
- 0FY2023
- 3MFY2024
- 0FY2025
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2025.
Subawards
Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.
This section could not be loaded right now. Reload the page to try again.
Teaming partners
Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.
This section could not be loaded right now. Reload the page to try again.
Competitors
Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.
This section could not be loaded right now. Reload the page to try again.
Lobbying and PAC activity
Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.
This section could not be loaded right now. Reload the page to try again.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.